Skip to main content
logo
Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
10.54
-0.38 (-3.44%)
At close: Aug 24, 2026, 4:00 PM EDT
10.54
0.00 (0.00%)
After-hours: Aug 24, 2026, 4:10 PM EDT

Lexaria Bioscience Ratios and Metrics

Millions USD. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Market Capitalization
17176281835
Market Cap Growth
11.65%-72.15%627.66%-51.77%-50.18%13.53%
Enterprise Value
14125351027
Last Close Price
10.9113.2058.6515.7544.4093.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
PS Ratio
88.6724.39133.1537.5668.9748.92
PB Ratio
3.816.628.073.172.312.71
P/TBV Ratio
3.916.428.223.292.362.74

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
EV/Sales Ratio
70.4717.46114.3321.5839.4437.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Debt / Equity Ratio
0.020.040.020.060.010.01
Net Debt / Equity Ratio
-0.81-0.71-0.84-0.49-0.80-0.89
Net Debt / EBITDA Ratio
0.480.161.140.210.942.09
Net Debt / FCF Ratio
0.470.181.280.221.242.92
Asset Turnover
0.030.110.080.040.020.09
Inventory Turnover
----2.112.39
Quick Ratio
9.561.566.105.9932.7978.90
Current Ratio
10.602.327.188.0435.9681.18
Return on Equity (ROE)
-162.77%-232.15%-112.36%-130.18%-71.35%-73.16%
Return on Assets (ROA)
-81.30%-111.49%-59.56%-73.59%-39.21%-44.17%
Return on Capital Employed (ROCE)
-170.40%-433.80%-73.30%-228.20%-86.60%-43.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Earnings Yield
-44.95%-69.13%-9.38%-78.45%-41.27%-11.39%
FCF Yield
-43.40%-60.84%-8.09%-69.63%-27.98%-11.28%
Buyback Yield / Dilution
-32.40%-45.34%-87.24%-12.38%-34.02%-58.34%
SEC Filings: 10-K · 10-Q